Florida · 86663

Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Early Antigen in Florida

Florida Medicare Avg
$12.84
0% above national avg
National Medicare Avg
$12.83
All states combined
Billed Charge (FL)
$124.78
What providers submit
Est. Commercial (FL)
$30.17
National avg: $28.74
Est. Cash / Self-Pay (FL)
$43.94
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

1.1K
Services in FL
14
Providers
N/A
Min Payment
N/A
Max Payment

Top Providers in Florida

Provider Medicare Services
Quest Diagnostics Clinical... $12.86 639
Quest Diagnostics Clinical... $12.80 185
Laboratory Corporation Of America $12.86 145
Nova Southeastern University, Inc $12.86 82
Access Medical Laboratories, Inc. $12.86 21

Florida Pricing in Context

In Florida, CPT code 86663 (Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Early Antigen) carries an average Medicare payment of $12.84 — 0% above the national benchmark of $12.83. 14 providers across the state submitted claims for this procedure in 2023, performing 1.1K total services. Individual payments in FL ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in Florida is $124.78, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Florida sits above the national Medicare average, commercial rates in the state may also run higher than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Immunology procedures, the estimated commercial insurance price in Florida lands near $30.17, with self-pay cash prices typically around $43.94. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Early Antigen cost in Florida?

The average Medicare payment for Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Early Antigen in Florida is $12.84, which is 0% above the national average of $12.83. Providers in FL typically bill $124.78 for this procedure.

What does Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Early Antigen cost with insurance in Florida?

With commercial insurance in Florida, Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Early Antigen costs an estimated $30.17. Without insurance, the estimated cash price is $43.94. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Early Antigen in Florida?

14 providers in Florida billed Medicare for Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Early Antigen in 2023, performing 1.1K total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Early Antigen cheaper in Florida than the national average?

No — Analysis For Antibody To Epstein-Barr Virus (mononucleosis Virus), Early Antigen costs 0% above the national average in Florida. The state average Medicare payment is $12.84 compared to $12.83 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial